Yongfeng Chen - Search Results

Year	Number of Results
2005	1
2006	2
2007	2
2008	4
2009	2
2010	4
2011	5
2012	3
2013	3
2014	7
2015	3
2016	4
2017	8
2018	4
2019	11
2020	21
2021	17
2022	30
2023	23
2024	13

1

HJM-561, a Potent, Selective, and Orally Bioavailable EGFR PROTAC that Overcomes Osimertinib-Resistant EGFR Triple Mutations.

Du Y, Chen Y, Wang Y, Chen J, Lu X, Zhang L, Li Y, Wang Z, Ye G, Zhang G. Du Y, et al. Among authors: chen y. Mol Cancer Ther. 2022 Jul 5;21(7):1060-1066. doi: 10.1158/1535-7163.MCT-21-0835. Mol Cancer Ther. 2022. PMID: 35499406

2

ZNF384: A Potential Therapeutic Target for Psoriasis and Alzheimer's Disease Through Inflammation and Metabolism.

Liu S, Yuan X, Su H, Liu F, Zhuang Z, Chen Y. Liu S, et al. Among authors: chen y. Front Immunol. 2022 May 20;13:892368. doi: 10.3389/fimmu.2022.892368. eCollection 2022. Front Immunol. 2022. PMID: 35669784 Free PMC article.

3

Combination of single-cell and bulk RNA seq reveals the immune infiltration landscape and targeted therapeutic drugs in spinal cord injury.

Zhang Q, Yu B, Zhang Y, Tian Y, Yang S, Chen Y, Wu H. Zhang Q, et al. Among authors: chen y. Front Immunol. 2023 Jan 19;14:1068359. doi: 10.3389/fimmu.2023.1068359. eCollection 2023. Front Immunol. 2023. PMID: 36742334 Free PMC article.

4

Gut microbiota and myeloproliferative neoplasms.

Adesola AA, Chen Y, Găman MA. Adesola AA, et al. Among authors: chen y. J Pak Med Assoc. 2023 Dec;73(12):2334-2336. doi: 10.47391/JPMA.23-99. J Pak Med Assoc. 2023. PMID: 38083909 Free article. No abstract available.

5

ALDH2 attenuates ischemia and reperfusion injury through regulation of mitochondrial fusion and fission by PI3K/AKT/mTOR pathway in diabetic cardiomyopathy.

Tan X, Chen YF, Zou SY, Wang WJ, Zhang NN, Sun ZY, Xian W, Li XR, Tang B, Wang HJ, Gao Q, Kang PF. Tan X, et al. Free Radic Biol Med. 2023 Feb 1;195:219-230. doi: 10.1016/j.freeradbiomed.2022.12.097. Epub 2022 Dec 30. Free Radic Biol Med. 2023. PMID: 36587924

6

NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia.

Chen Y, Zou Z, Găman MA, Xu L, Li J. Chen Y, et al. Cell Death Discov. 2023 Jun 30;9(1):208. doi: 10.1038/s41420-023-01528-5. Cell Death Discov. 2023. PMID: 37391442 Free PMC article. Review.

7

Identification of potential biomarkers and infiltrating immune cells from scalp psoriasis.

Liu S, Zhuang Z, Liu F, Yuan X, Zhang Z, Liang X, Li X, Chen Y. Liu S, et al. Among authors: chen y. Gene. 2024 Jan 30;893:147918. doi: 10.1016/j.gene.2023.147918. Epub 2023 Oct 21. Gene. 2024. PMID: 37871808

8

Multicentric reticulohistiocytosis successfully treated with baricitinib.

Chen Y, Li J, Zhu Y. Chen Y, et al. Eur J Dermatol. 2022 Jul 1;32(4):539-540. doi: 10.1684/ejd.2022.4307. Eur J Dermatol. 2022. PMID: 36301761 English. No abstract available.

9

The involvement of noncanonical Wnt signaling in cancers.

Chen Y, Chen Z, Tang Y, Xiao Q. Chen Y, et al. Biomed Pharmacother. 2021 Jan;133:110946. doi: 10.1016/j.biopha.2020.110946. Epub 2020 Nov 16. Biomed Pharmacother. 2021. PMID: 33212376 Free article. Review.

10

Advance Care Planning in Hong Kong.

Chan CWH, Chen YF, Chan HYL. Chan CWH, et al. Z Evid Fortbild Qual Gesundhwes. 2023 Aug;180:90-93. doi: 10.1016/j.zefq.2023.05.015. Epub 2023 Jul 1. Z Evid Fortbild Qual Gesundhwes. 2023. PMID: 37394336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year